Shanghai, China, 15th Dec 2025 – AGIBOT, a leading company in general-purpose embodied robotics, participated in the GIS Summit 2025, where it showcased its flagship AGIBOT A2. The robot stands as the first full-size humanoid to achieve large-scale commercial deployment and is the only one globally with full CR, FCC, and CE certifications, making it a deployment-ready solution for global enterprises.

The GIS Summit 2025, held from December 2 to 4 in Hong Kong, focused on the intersection of “Artificial Intelligence and Green Technology.” AGIBOT’s presence demonstrated its leadership in the global humanoid robot industry and its commitment to practical, practical applications of embodied AI.

“AI + Robotics is creating the embodied intelligence path to green manufacturing,” said Wang Chuang, Partner, Senior Vice President, and President of the General Business Unit at AGIBOT, during a keynote speech. “Embodied AI is transforming from ‘functional’ to ‘intelligent & usable,’ creating new value for industries. The AGIBOT A2 is a prime example, addressing real-world pain points and moving humanoid robotics from concept to commercial reality.”

AGIBOT A2’s capabilities are built on three pillars: Interactive Intelligence, Motion Intelligence, and Task Intelligence. This full-stack physical intelligence solution allows it to operate reliably in real-world settings, offering businesses a tangible way to enhance operations and engage audiences.

AGIBOT’s booth also featured its complete technological ecosystem:

AGIBOT X2: A half-size humanoid designed for the entertainment and commercial performance industry.

AGIBOT D1 Pro/Edu: A rugged, intelligent quadruped robot ideal for education, research, and industrial inspection.

The success of AGIBOT was driven by its proprietary “1 Ontology + 3 Intelligence” architecture, which seamlessly integrates manipulation, interaction, and locomotion intelligence. This holistic approach enables a comprehensive product portfolio and empowers partners to transform AI-driven robotics into a tangible competitive advantage.

Media Contact

Organization: Shanghai Zhiyuan Innovation Technology Co., Ltd.

Contact Person: Jocelyn Lee

Website: https://www.zhiyuan-robot.com

Email: Send Email

City: Shanghai

Country:China

Release id:39051

The post AGIBOT A2 Redefined Real-World AI at GIS Summit 2025 as the Certified and Deployment-Ready Humanoid Robot appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

Shanghai, China, 15th Dec 2025 – At the GIS Summit 2025, held in Hong Kong from December 2 to 4 under the theme “Artificial Intelligence and Green Technology,” the field of embodied intelligent robotics witnessed a significant announcement: the launch of AGIBOT A2. As the world’s first full-size humanoid robot to obtain comprehensive CR, FCC, and CE certifications, it marks the industry’s formal transition from laboratory concepts to a new phase of compliant, large-scale commercial deployment.

From Functional to Intelligently Usable: Certification Underpins Scalable Deployment Capability

In his keynote address, Wang Chuang, Partner, Senior Vice President, and President of the General Business Unit at AGIBOT, emphasized that embodied intelligence is undergoing a crucial shift from being merely “functional” to becoming truly “intelligent and usable.” The AGIBOT A2 has garnered attention precisely by pioneering solutions to the “access” challenges faced by humanoid robots entering real-world scenarios. By securing internationally recognized certifications, it demonstrates compliance with global safety and quality standards, paving the way for cross-regional and cross-industry deployment.

This robot is not merely a technological platform but a ready-to-deploy solution tailored for high-demand scenarios such as technology exhibitions, corporate showcases, and cultural-tourism events. By integrating three core technological pillars—Interactive Intelligence, Motion Intelligence, and Task Intelligence—it delivers stable and efficient performance in dynamic environments. Having moved beyond the prototype stage, it now stands as a commercially viable robotic product ready for tangible integration into business operations.

Full Product Lineup Showcases Holistic Embodied Intelligence Ecosystem

At the AGIBOT booth, the A2 was presented alongside two other flagship products, forming a comprehensive product matrix:

– AGIBOT X2: A half-size humanoid robot designed for the entertainment and commercial performance industry, emphasizing dynamic interaction and stage presence.

– AGIBOT D1 Pro/Edu: An intelligent quadruped robot with robust motion performance and scalability, suitable for education, research, and industrial inspection.

This combination reflects AGIBOT’s ability to cover diverse scenarios and further validates the extensibility and integrity of its technological ecosystem.

The “1 Ontology + 3 Intelligence Interaction” Architecture Drives Cross-Industry Digital Transformation

AGIBOT builds upon a robotic ontology as its foundation, deeply integrating Manipulation Intelligence, Interaction Intelligence, and Locomotion Intelligence to form a “1 Ontology + 3 Intelligences” system architecture. This design not only supports the development of a full product portfolio but also enables the delivery of comprehensive solutions spanning commercial services, industrial manufacturing, and education.

Today, AGIBOT has established a leading full-stack technology ecosystem, helping partners across sectors transform embodied AI from a concept into tangible gains in operational efficiency and competitive advantage. Amid the broader trend of integrating green manufacturing and AI, robots characterized by compliance, stability, and scenario adaptability are increasingly becoming essential infrastructure for corporate digital and intelligent transformation.

Media Contact

Organization: Shanghai Zhiyuan Innovation Technology Co., Ltd.

Contact Person: Jocelyn Lee

Website: https://www.zhiyuan-robot.com

Email: Send Email

City: Shanghai

Country:China

Release id:39052

The post GIS Summit 2025 Spotlight – The Certified and Deployment-Ready AGIBOT A2 Leads a New Era of Large-Scale Deployment appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

• Description: Learn how Zealthy is redefining access to GLP‑1 medications like semaglutide and tirzepatide through affordable pricing, compounding partnerships, and streamlined care.

Canton, Michigan, 15 Dec 2025, ZEX PR WIRE, For years, a frustrating paradox has defined the weight loss landscape: the most effective treatments were often the least accessible. Medications like semaglutide and tirzepatide, the active ingredients in Ozempic® and Mounjaro®, have demonstrated remarkable efficacy, with patients achieving average weight loss of 15-20%. Yet, their high costs and complex insurance hurdles placed them out of reach for millions. As we look toward 2026, this paradigm is finally shifting, not just through market evolution, but through the deliberate, disruptive strategies of forward-thinking healthcare companies. Zealthy is at the forefront of this change, architecting a new model of care designed to make these life-changing medications affordable and accessible for the long term. “Effective weight-loss medication shouldn’t be reserved for the few who can afford it. Our mission is to break that model entirely and prove that affordability and clinical quality can coexist at scale,” says Kyle Robertson, Founder & CEO of Zealthy.

The challenge has never been a lack of effective tools, but a failure of the system to deliver them. Traditional healthcare pathways are often fragmented and riddled with friction, leaving patients to navigate a maze of appointments, pharmacy negotiations, and insurance denials. Zealthy was founded on the principle that modern technology, when paired with a human-centric approach, could dismantle these barriers. The company’s vision for 2026 and beyond is not merely to sell medication, but to build a sustainable ecosystem where cost, convenience, and clinical excellence converge.

Zealthy Is Redefining Affordability Through a Hybrid Model

“The future of metabolic health is about creating an ecosystem where people get long-term support, clear pricing, and real outcomes,” Robertson says. The cornerstone of Zealthy’s strategy is its unique, flexible approach to pricing and medication access. Recognizing that no single financial solution works for everyone, the platform was designed to serve both insured and uninsured patients with equal efficiency. For those with insurance, Zealthy’s dedicated coordinators navigate the complexities of prior authorizations, a critical service many providers do not offer. This support can dramatically reduce out-of-pocket costs for brand-name GLP-1s like Wegovy® and Zepbound, often bringing the price down to as little as $25 per month.

For the millions without adequate coverage, Zealthy provides access to high-quality compounded semaglutide and tirzepatide. By partnering with state-licensed sterile compounding pharmacies, Zealthy offers these medications at a fraction of the brand-name cost, with prices starting as low as $151 per month. This dual-pathway system ensures that a patient’s financial situation does not dictate their ability to access treatment. A happy Zealthy member, Douglas, is loving his experience with Zealthy and said, “Zealthy has met all my needs and taken extremely good care of me. Between their support and my lifestyle changes, I’m seeing results I never thought possible. With Zealthy as my partner, I feel like success is the only outcome.”

Driving Down Costs with Supply and Scale

Beyond its pricing structure, Zealthy is innovating its supply chain to create further efficiencies that will become even more critical by 2026. Unlike most telehealth services that dispense medication one month at a time, Zealthy offers 3-, 6-, and 12-month supply options. This model achieves several key objectives. First, it reduces administrative and shipping overhead, generating savings that are passed directly to the patient. Second, it significantly improves medication adherence, a crucial factor in achieving and maintaining long-term weight loss.

As Zealthy scales its operations, its growing member base gives it greater purchasing power, allowing for more favorable negotiations with pharmacy partners. This economy of scale is central to its long-term vision of driving down the baseline cost of GLP-1 treatments, making them a staple of metabolic care rather than a luxury.

The Power of Zealthy’s Asynchronous, Tech-Enabled Care

Another key component of Zealthy’s cost-effective model is its sophisticated yet intentionally simple clinical platform. By prioritizing asynchronous communication, Zealthy eliminates the need for costly and time-consuming video visits for most members. Patients complete a secure medical intake, which is thoroughly reviewed by a licensed provider. This streamlined process allows clinicians to make faster prescribing decisions without sacrificing clinical rigor, resulting in a smoother, lower-friction experience for patients.

This tech-enabled efficiency reduces the operational burden on providers, allowing them to support a larger patient panel effectively. The savings generated from this lean operational model are reinvested into the platform and contribute to keeping membership and medication costs low. At just $39 for the first month, Zealthy’s membership fee is one of the most competitive in the industry, reflecting a commitment to removing every possible barrier to entry.

Zealthy’s Vision for Integrated, Lifelong Health

Looking ahead to 2026, Zealthy’s strategy extends beyond just making medication affordable. The company understands that sustainable health outcomes require an integrated approach that addresses biology, behavior, and lifestyle. Every member is paired with a care team, including a prescribing provider and a dedicated coach, who offer continuous support through the platform’s unlimited messaging feature. This holistic model ensures patients are not just receiving a prescription but are guided through their entire journey. “The coaches have been incredibly thoughtful and supportive. They check in, answer questions, and genuinely care about how I’m doing. It’s made all the difference in keeping me motivated,” says a Zealthy member.

By expanding its services to include mental health, primary care, and more, Zealthy is building a comprehensive healthcare ecosystem. This integrated vision reinforces the idea that weight management is a component of overall wellness, not an isolated goal. As the healthcare landscape evolves, the companies that thrive will be those that can provide seamless, personalized, and affordable care at scale. By laying the groundwork today, Zealthy is not just preparing for the future of medicine, it is actively building it.

To learn more visit: https://www.getzealthy.com/